47 results
8-K
EX-10.2
TXMD
TherapeuticsMD Inc
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
Purchase Plan.
“Independent Financial Expert” shall mean a nationally recognized accounting, investment banking or consultant firm, which firm does … on such Trading Day reasonably determined, using a volume-weighted average method, by an Independent Financial Expert appointed (and compensated
8-K
EX-10.2
TXMD
TherapeuticsMD Inc
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
under the Company’s 2019 Stock Incentive Plan or the Company’s 2020 Employee Stock Purchase Plan.
“Independent Financial Expert” shall mean … average method, by an Independent Financial Expert appointed (and compensated by the Company) for such purpose). The VWAP will be determined without
8-K
EX-10.2
1aq0w918nkziifxjevpu
1 Aug 22
TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital
6:55am
8-K
EX-99.1
nogokq8qq7n848m0dlo
13 Jan 21
Entry into a Material Definitive Agreement
8:50am
8-K
EX-99.1
incsk fjy
10 Jun 19
Regulation FD Disclosure
2:28pm